CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 267 enrolled
Drug / intervention
Flavor Ban +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04259749
NCT04259749N/ACompleted

Experimentally Testing Legally Feasible Regulatory Options for Reducing the Impact of the Point-of-sale Retail Environment on Adolescent Tobacco Use

RAND·interventional·Posted Feb 6, 2020·Updated Oct 30, 2023

In Brief

A clinical study evaluating Flavor Ban, Menthol Ban, and 1 other intervention for Tobacco Use. Completed, enrolled 267 participants across 1 site.

Detailed Summary

The overall aim of this research is to experimentally evaluate different, legally-viable approaches to reducing the impact of the point-of-sale (POS) retail environment on adolescent tobacco use risk. This study will be investigating the regulations for four classes of tobacco products (cigarettes, e-cigarettes, smokeless tobacco, little cigars/cigarillos). Study 1 (study 1 out of 3 proposed) will examine whether eliminating the sale of flavored tobacco products at POS reduced adolescents' tobacco use risk.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 6, 2020
Enrollment StartJan 16, 2020
Primary CompletionMay 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 6.4 years ago

Interventions

Flavor Banother

Only flavored tobacco products are banned

Menthol Banother

Mentholated products are banned

All flavored and mentholated products availableother

No bans: All tobacco products are available